
Gilead Sciences
North America, California, United States, Foster City
Description
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Investor Profile
Gilead Sciences has backed more than 70 startups, with 2 new investments in the last 12 months alone. The firm has led 44 rounds, about 63% of its total and boasts 17 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Post Ipo Equity, Series B rounds (top funding stages).
- Majority of deals are located in United States, Belgium, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Non Profit.
- Led 2 rounds in the past year.
Stage Focus
- Grant (46%)
- Post Ipo Equity (19%)
- Series B (16%)
- Series A (6%)
- Corporate Round (6%)
- Series C (3%)
- Series Unknown (3%)
- Seed (1%)
- Undisclosed (1%)
Country Focus
- United States (97%)
- Belgium (1%)
- United Kingdom (1%)
Industry Focus
- Health Care
- Biotechnology
- Non Profit
- Therapeutics
- Medical
- Pharmaceutical
- Clinical Trials
- Life Science
- Social
- Communities
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Gilead Sciences frequently co-invest with?
What are some of recent deals done by Gilead Sciences?
Find More Investors Like Gilead Sciences
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









